Follow the people · Insider
Konstantinos Xynos
Konstantinos Xynos files insider transactions with the SEC as a chief medical officer of Replimune Group (REPL). We hold 2 disclosed purchases and sales filed since 5 December 2022, 1 of them in the last 90 days.
- Files forREPL
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure12 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 December 2022 — 10 August 2026Chief Medical Officer · Replimune Group (REPL)20 Form 4 lines · source: SEC Form 4
Everything they disclosed
20 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 11,447 shares of Replimune GroupSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- ▼ sold on the open market 14,023 shares of Replimune GroupSEC Form 420 May 2026Common Stock · traded 18 May 2026 · filed 20 May 2026
- was granted 50,000 shares of Replimune GroupSEC Form 47 April 2026Common Stock · traded 1 April 2026 · filed 7 April 2026
- was granted 75,000 shares of Replimune Group (a derivative holding)SEC Form 47 April 2026Employee Stock Option (right to buy) · traded 1 April 2026 · filed 7 April 2026
- was granted 60,000 shares of Replimune GroupSEC Form 419 December 2025Common Stock · traded 19 December 2025 · filed 19 December 2025
- ▼ sold on the open market 7,248 shares of Replimune GroupSEC Form 419 November 2025Common Stock · traded 17 November 2025 · filed 19 November 2025
- ▼ sold on the open market 7,952 shares of Replimune GroupSEC Form 422 May 2025Common Stock · traded 20 May 2025 · filed 22 May 2025
- was granted 67,500 shares of Replimune Group (a derivative holding)SEC Form 43 April 2025Employee Stock Option (right to buy) · traded 1 April 2025 · filed 3 April 2025
- was granted 45,000 shares of Replimune GroupSEC Form 43 April 2025Common Stock · traded 1 April 2025 · filed 3 April 2025
- ▼ sold on the open market 7,246 shares of Replimune GroupSEC Form 420 November 2024Common Stock · traded 18 November 2024 · filed 20 November 2024
- ▼ sold on the open market 15,881 shares of Replimune GroupSEC Form 410 June 2024Common Stock · traded 7 June 2024 · filed 10 June 2024
- ▼ sold on the open market 6,367 shares of Replimune GroupSEC Form 420 May 2024Common Stock · traded 16 May 2024 · filed 20 May 2024
- was granted 80,000 shares of Replimune Group (a derivative holding)SEC Form 43 April 2024Employee Stock Option (right to buy) · traded 1 April 2024 · filed 3 April 2024
- was granted 26,665 shares of Replimune GroupSEC Form 43 April 2024Common Stock · traded 1 April 2024 · filed 3 April 2024
- ▼ sold on the open market 7,313 shares of Replimune GroupSEC Form 417 November 2023Common Stock · traded 16 November 2023 · filed 17 November 2023
- ▼ sold on the open market 771 shares of Replimune GroupSEC Form 418 May 2023Common Stock · traded 16 May 2023 · filed 18 May 2023
- was granted 75,000 shares of Replimune Group (a derivative holding)SEC Form 44 April 2023Employee Stock Option (right to buy) · traded 1 April 2023 · filed 4 April 2023
- was granted 50,000 shares of Replimune GroupSEC Form 44 April 2023Common Stock · traded 1 April 2023 · filed 4 April 2023
- was granted 26,250 shares of Replimune Group (a derivative holding)SEC Form 45 December 2022Employee Stock Option (right to buy) · traded 1 December 2022 · filed 5 December 2022
- was granted 17,500 shares of Replimune GroupSEC Form 45 December 2022Common Stock · traded 1 December 2022 · filed 5 December 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.